Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ME2 | P23368 | 5/20 | 0.57 |
| ▸ | ME1 | P48163 | 5/20 | 0.57 |
| ▸ | ME3 | Q16798 | 5/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.49 |
| ▸ | GPR4 | P46093 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL653012 | 0.86 | NPC1 (0.54) | NPC1TDP1NAAAGAAFKBP1A | |
| SCHEMBL653041 | 0.86 | GFER (0.58) | ME2ME1ME3NPC1TDP1 | |
| SCHEMBL1838692 | 0.85 | NPC1 (0.73) | ME2ME1ME3NPC1TDP1 | |
| SCHEMBL8934908 | 0.85 | ME2 (0.57) | ME2ME1ME3NPC1POLB | |
| Hydrochloric Acid SCHEMBL3086821 | 0.84 | NPC1 (0.71) | ME2ME1ME3NPC1TDP1 | |
| Hydrochloric Acid SCHEMBL9951192 | 0.83 | ME2 (0.56) | ME2ME1ME3NPC1POLB | |
| SCHEMBL10483827 | 0.83 | GAA (0.52) | NPC1TDP1NAAAGAAGPR4 | |
| SCHEMBL24648923 | 0.82 | FKBP1A (0.71) | NPC1TDP1NAAAGAAFKBP1A | |
| SCHEMBL19590776 | 0.80 | FKBP1A (0.50) | NPC1TDP1NAAAGAAFKBP1A | |
| SCHEMBL13068970 | 0.79 | ENPP2 (0.53) | NPC1TDP1FKBP1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996029088-A1 | NOVEL PIPERAZINE DERIVATIVES AS TYPE IL-1 RECEPTOR ANTAGONISTS | AFFYMAX TECHNOLOGIES N.V. (AN) | 1996-09-26 | — | — | WO | disclosed |